Kristina Lindemann

13PUBLICATIONS
104CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMedical ethics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 28, 2026
Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off-the-shelf targeted NGS panel.

|Feb 12, 2026
Applicability of mitotic figure counting by deep learning: a development and pan-cancer validation study.

Joakim Kalsnes, Maria X Isaksen, Frida Julbø

|Feb 10, 2026
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial.

Kathinka Schmidt Slørdahl, Katarina Puco, Ragnhild Sørum Falk

|Dec 03, 2025
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial.

Philipp Harter, Frederik Marmé, Andrés Redondo

|Aug 09, 2025
Empowerment and quality of life in gynecological cancer survivors: Outcomes from a multicenter quasi-experimental cohort study from Norway (the LETSGO trial).

Ingvild Vistad, Mette Skorstad, Sveinung Berntsen

|Jan 08, 2025
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study.

Peter Hillemanns, Michal Zikan, Frédéric Forget

Pageof 3

Frequent Collaborators

3 joint publications

Andreas Kleppe

2 joint publications

Philipp Harter

2 joint publications

Jalid Sehouli

2 joint publications

Nicole Concin